This web site use private and third party cookies to optimize your navigation, suit your preferences and perform analytical tasks. By continuing browsing accept our Cookies Policy.

Accept
24 September 2022Bilbao Campus

September 24. Deusto joins the World Cancer Research Day Initiative

The University of Deusto joins the World Cancer Research Day which celebrates every September 24 since 2016. The aim of this initiative is to boost the value and impact of cancer research as an asset to both reduce its evolution as well as improve the quality of life in patients.


Cancer shall become the leading cause of death worldwide with an increase up to 21,6 million new cases per year by 2030. Although cancer research is seen as an imperative strategy to progress on the prevention and treatment of the disease, it still has to face great challenges such as, among others, improving international collaborative networks or setting up sustainable funding models, among others.


What type of research on cancer does the University of Deusto conduct?


The University of Deusto, as stated in the Strategic Plan 2019-22, commits itself to conduct innovative research with scientific and social impact facing both global and local challenges.


Thus, research teams from different disciplines from the University of Deusto work collaboratively with local, regional and European organizations as to:

 

  • Develop prevention, intervention and care programmes for patients with cancer.
  • Improve the quality of life of patients with cancer by developing machine learning models to predict toxicity levels of current treatments and late sequelae.
  • Design innovative and efficient programmes based on a combination of physical activity with conventional treatment.
  • Support personalise treatment in oncology by developing Deep Learning technologies to evaluate damages in histopathological images.
  • Understand the role of the physical activity regarding the different facets of cancer (hematologic, physical, psychological…).
  • Use Big Data and IA technologies to diagnose or to take care of patients with cancer (tele-health, tele-treatment).